AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Karsila-Tenovuo, S Jahnukainen, K Peltomaki, T Minn, H Kulmala, J Salmi, TT Ronning, O
Citation: S. Karsila-tenovuo et al., Disturbances in craniofacial morphology in children treated for solid tumors, ORAL ONCOL, 37(7), 2001, pp. 586-592

Authors: Nuutinen, J Sonninen, P Lehikoinen, P Sutinen, E Valavaara, R Eronen, E Norrgard, S Kulmala, J Teras, M Minn, H
Citation: J. Nuutinen et al., Radiotherapy treatment planning and long-term follow-up with [C-11]methionine pet in patients with low-grade astrocytoma, INT J RAD O, 48(1), 2000, pp. 43-52

Authors: Ouwehand, AC Tolkko, S Kulmala, J Salminen, S Salminen, E
Citation: Ac. Ouwehand et al., Adhesion of inactivated probiotic strains to intestinal mucus, LETT APPL M, 31(1), 2000, pp. 82-86

Authors: Pulkkinen, JO Servomaa, K Pekkola, K Kulmala, J Grenman, R
Citation: Jo. Pulkkinen et al., The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival, ANTICANC R, 20(3A), 2000, pp. 1503-1511

Authors: Engblom, P Pulkkinen, JO Rantanen, V Hirvonen, H Kulmala, J Grenman, R Grenman, S
Citation: P. Engblom et al., Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis, EUR J CANC, 35(2), 1999, pp. 284-288

Authors: Lampisuo, M Liippo, J Vainio, O McNagny, KM Kulmala, J Lassila, O
Citation: M. Lampisuo et al., Characterization of prethymic progenitors within the chicken embryo, INT IMMUNOL, 11(1), 1999, pp. 63-69

Authors: Turpeinen, T Kulmala, J Nevo, E
Citation: T. Turpeinen et al., Genome size variation in Hordeum spontaneum populations, GENOME, 42(6), 1999, pp. 1094-1099

Authors: Engblom, P Rantanen, V Kulmala, J Grenman, S
Citation: P. Engblom et al., Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effectin epithelial ovarian carcinoma in vitro, CANCER, 86(10), 1999, pp. 2066-2073

Authors: Engblom, P Rantanen, V Kulmala, J Helenius, H Grenman, S
Citation: P. Engblom et al., Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines, BR J CANC, 79(2), 1999, pp. 286-292
Risultati: 1-9 |